Daniel J. Drucker
Impact in
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
- Diabetes Management and Research
- Endocrine and Autonomic Systems top 0.02%
- Regulation of Appetite and Obesity
Papers in
-
- Diabetes Treatment and Management 262
- Diabetes Management and Research 29
- Surgery 200
- Pancreatic function and diabetes 174
- Co-authors
- Laurie L. Baggio (66 shared papers)Michael A. Nauck (2 shared papers)Patricia L. Brubaker (39 shared papers)Jonathan E. Campbell (15 shared papers)Bernardo Yusta (42 shared papers)John R. Ussher (13 shared papers)L. Sylvia (16 shared papers)Joel F. Habener (12 shared papers)
- Journals
- Diabetes (55 papers)Endocrinology (53 papers)Molecular Metabolism (27 papers)Cell Metabolism (21 papers)Journal of Biological Chemistry (19 papers)
- Partner nations
- CanadaUnited StatesGermany
In The Last Decade
Daniel J. Drucker
420 papers receiving 59.3k citations
Daniel J. Drucker's Hit Papers
Peers
Comparison fields: 5 of 175
- Endocrinology, Diabetes and Metabolism 33.6k
- Endocrine and Autonomic Systems 5.6k
- Surgery 20.3k
- Cellular and Molecular Neuroscience 6.7k
- Physiology 8.0k
Countries citing papers authored by Daniel J. Drucker
This map shows the geographic impact of Daniel J. Drucker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Drucker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Drucker more than expected).
Fields of papers citing papers by Daniel J. Drucker
This network shows the impact of papers produced by Daniel J. Drucker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Drucker. The network helps show where Daniel J. Drucker may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. Drucker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 428 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Hit paper breakdown → | 2006 | 3082 |
| 2 | Biology of Incretins: GLP-1 and GIP Hit paper breakdown → | 2007 | 2892 |
| 3 | The biology of incretin hormones Hit paper breakdown → | 2006 | 1739 |
| 4 | Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Hit paper breakdown → | 2018 | 1354 |
| 5 | Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action Hit paper breakdown → | 2013 | 1159 |
| 6 | Normalization of obesity-associated insulin resistance through immunotherapy Hit paper breakdown → | 2009 | 1110 |
| 7 | FTO Obesity Variant Circuitry and Adipocyte Browning in Humans Hit paper breakdown → | 2015 | 893 |
| 8 | Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways Hit paper breakdown → | 2008 | 885 |
| 9 | Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study Hit paper breakdown → | 2008 | 869 |
| 10 | Glucagon-like peptide-1 receptor is involved in learning and neuroprotection Hit paper breakdown → | 2003 | 725 |
| 11 | Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Hit paper breakdown → | 1996 | 715 |
| 12 | Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Hit paper breakdown → | 1987 | 705 |
| 13 | Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene Hit paper breakdown → | 1996 | 642 |
| 14 | Incretin-based therapies for type 2 diabetes mellitus Hit paper breakdown → | 2009 | 544 |
| 15 | Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation Hit paper breakdown → | 2010 | 521 |
| 16 | The Cardiovascular Biology of Glucagon-like Peptide-1 Hit paper breakdown → | 2016 | 504 |
| 17 | 2002 | 496 | |
| 18 | Advances in oral peptide therapeutics Hit paper breakdown → | 2019 | 492 |
| 19 | 2000 | 486 | |
| 20 | 2007 | 484 |
About Daniel J. Drucker
Daniel J. Drucker is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Cellular and Molecular Neuroscience and Epidemiology, having authored 428 papers that have together received 60.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (262 papers), Pancreatic function and diabetes (174 papers), Neuropeptides and Animal Physiology (68 papers), Metabolism, Diabetes, and Cancer (50 papers), Neuroendocrine Tumor Research Advances (37 papers), Peptidase Inhibition and Analysis (36 papers), Regulation of Appetite and Obesity (35 papers) and Diabetes Management and Research (29 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (33.6k citations), Endocrine and Autonomic Systems (5.6k citations), Surgery (20.3k citations), Cellular and Molecular Neuroscience (6.7k citations) and Physiology (8.0k citations). Daniel J. Drucker has collaborated with scholars based in Canada, United States and Germany. Frequent co-authors include Laurie L. Baggio, Michael A. Nauck, Patricia L. Brubaker, Jonathan E. Campbell, Bernardo Yusta, John R. Ussher, L. Sylvia, Joel F. Habener, Julie A. Lovshin and Erin E. Mulvihill. Their work appears in journals such as Diabetes, Endocrinology, Molecular Metabolism, Cell Metabolism and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.